ArticleJACC. Case reports2026
Minimally Invasive Endoscopic Surgery in Patients With Previous Cardiac or Thoracic Surgery.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Redo Endoscopic Coronary Artery Bypass Grafting: Turning the Page on Repeat Sternotomy.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMinimally invasive, sternal-sparing techniques offer an alternative to conventional repeat sternotomy in patients with prior cardiothoracic surgery, aiming to achieve durable coronary revascularization while minimizing procedural risk. CASE SUMMARY: Between 2022 and 2025, six patients underwent redo minimally invasive endoscopic-assisted coronary artery bypass grafting (Endo-CAB) with endoscopically harvested graft conduits, and a beating-heart anastomosis on the left anterior descending artery was made through a mini-thoracotomy. This case series presents patients with diverse prior cardiac and thoracic surgical histories. Although percutaneous coronary intervention was considered because of the increased operative risk, a minimally invasive surgical approach was preferred given unfavorable coronary anatomy and advanced atherosclerosis. All patients had an uneventful postoperative recovery. DISCUSSION: Redo Endo-CAB avoids repeat sternotomy, reduces surgical trauma, and facilitates a safe internal mammary artery harvest. This approach combines the durability of surgical revascularization with reduced perioperative morbidity in selected high-risk patients. TAKE-HOME MESSAGE: Redo Endo-CAB is a viable and promising revascularization strategy for selected patients with prior cardiothoracic surgery when performed at experienced centers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.